---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "viaEzQL4vCM+GbkBaC5P9jFiKduLyBnJMoyyNv7QOVAvZw5Ga/MW+cQpSRrWFC7cVFAjmXyJEe9eGgS6cWfA9IdF5fcIjEKnSu1E4CGSshMf/Y6Dpdp627fAIq5ReUQRrL0o15wiSB5RLO2jUvQwWVdzFGL2f2xlRH/TOY04HjPYGHoYRh1ZM4KEazhd69OA9Z4oeMha9stQlNnOP1fsRquy+lUS5yX0RQf3GY2UYK25uUma8iYSvFm46BWRx4/a0ZvHXx2/zgDYrO+cvrkXiXmRDLfh9pKb4q66GRFKS68kpvyam6/Cff6W8ugAlSnn;H1C/W/osEk5ZK5ecHrD/tg=="
---

